Vyvgart

Vyvgart (efgartigimod alfa) is a subcutaneous therapy for adults with generalized myasthenia gravis. This immunomodulator targets the neonatal Fc receptor to reduce pathogenic antibodies. It offers targeted immune modulation with convenient at-home administration options.

Vyvgart is used to treat generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive. It helps manage symptoms by reducing the presence of harmful antibodies that interfere with nerve-muscle communication. Patients often ask what is efgartigimod alfa used for, and this medication is specifically indicated for this autoimmune condition.

Vyvgart works by temporarily lowering immunoglobulin G antibody levels in the bloodstream. This process helps reduce muscle weakness and fatigue associated with myasthenia gravis. Patients may notice improved daily functioning and reduced symptom severity over time.

Store Vyvgart refrigerated between 2°C and 8°C (36°F and 46°F) in its original packaging. Protect from light and avoid freezing. Keep out of reach of children and pets. Dispose of used autoinjectors in a sharps container as directed.

Vyvgart may interact with other medications that affect the immune system, including immunosuppressants and corticosteroids. Live vaccines should be avoided during treatment due to reduced immune response. Always inform healthcare providers about all medications and supplements being taken.